DK123288D0 - Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen - Google Patents

Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen

Info

Publication number
DK123288D0
DK123288D0 DK123288A DK123288A DK123288D0 DK 123288 D0 DK123288 D0 DK 123288D0 DK 123288 A DK123288 A DK 123288A DK 123288 A DK123288 A DK 123288A DK 123288 D0 DK123288 D0 DK 123288D0
Authority
DK
Denmark
Prior art keywords
antigen
procedure
surface anti
yeast
recombinant hepatitis
Prior art date
Application number
DK123288A
Other languages
English (en)
Other versions
DK123288A (da
Inventor
William M Hurni
Dennis J Kubek
William J Miller
Mark S Rienstra
Edward M Scolnick
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK123288D0 publication Critical patent/DK123288D0/da
Publication of DK123288A publication Critical patent/DK123288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK123288A 1987-03-09 1988-03-08 Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen DK123288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2334787A 1987-03-09 1987-03-09

Publications (2)

Publication Number Publication Date
DK123288D0 true DK123288D0 (da) 1988-03-08
DK123288A DK123288A (da) 1988-09-10

Family

ID=21814559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK123288A DK123288A (da) 1987-03-09 1988-03-08 Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen

Country Status (10)

Country Link
EP (1) EP0291146B1 (da)
JP (1) JPS63270629A (da)
AT (1) ATE93891T1 (da)
AU (1) AU608813B2 (da)
CA (1) CA1304887C (da)
CY (1) CY1790A (da)
DE (1) DE3883596T2 (da)
DK (1) DK123288A (da)
ES (1) ES2043808T3 (da)
HK (1) HK48094A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960023066A (ko) * 1994-12-10 1996-07-18 성재갑 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
JPS62298536A (ja) * 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
ATE91304T1 (de) * 1987-02-27 1993-07-15 Merck & Co Inc Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Also Published As

Publication number Publication date
ATE93891T1 (de) 1993-09-15
EP0291146B1 (en) 1993-09-01
HK48094A (en) 1994-05-20
DE3883596D1 (de) 1993-10-07
CY1790A (en) 1995-10-20
CA1304887C (en) 1992-07-07
AU608813B2 (en) 1991-04-18
DE3883596T2 (de) 1994-02-17
DK123288A (da) 1988-09-10
JPS63270629A (ja) 1988-11-08
EP0291146A2 (en) 1988-11-17
AU1277888A (en) 1988-09-08
ES2043808T3 (es) 1994-01-01
EP0291146A3 (en) 1989-12-06

Similar Documents

Publication Publication Date Title
DE69332334D1 (de) Verfahren zur verstärkten expression von virusproteinen
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
DK383189A (da) Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer
ATE97164T1 (de) Rekombinantes vaccinia-virus mva.
CA2020668A1 (en) Fused or hybrid protein comprising viral antigen and lymphokine
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
DK235289A (da) Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter
AU580059B2 (en) Vaccine against rabies and preparation process thereof
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ATE121754T1 (de) Vakzine gegen bordetella.
EP0161095A3 (en) Vaccine against urinary infection
DK123288D0 (da) Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen
DK373489D0 (da) Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler
FI943626A (fi) Rekombinanttiadenovirusrokotteita
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
DE3587205D1 (de) Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
DK100888A (da) Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer
PT81052B (pt) Processo de preparacao de saccharomyces recombinantes
DK43991A (da) Allele varianter af plasmodium falciparum merozoitoverfladeantigen
EP0293201A3 (en) Method of vaccination for hepatitis b virus
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
NZ230996A (en) Immunogenic recombinant polypeptides and their use in the production of neutralising antibodies against viral haemorrhagic septicaemia virus
ATE159758T1 (de) Azelluläre impfstoffe
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment